These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 1260185)

  • 1. Proceedings: Inhibition of phagocytosis by mepacrine.
    Baker DJ; Trist DG; Weatherall M
    Br J Pharmacol; 1976 Mar; 56(3):346P-347P. PubMed ID: 1260185
    [No Abstract]   [Full Text] [Related]  

  • 2. Mepacrine uptake by granulocytes [proceedings].
    Read NG; Trist DG
    Br J Pharmacol; 1978 Jun; 63(2):410P. PubMed ID: 667483
    [No Abstract]   [Full Text] [Related]  

  • 3. Phagocytic properties of granulocytes after intravenous injection of ioxaglate or iohexol.
    Rasmussen F; Georgsen J; Antonsen S; Grunnet N
    Acta Radiol; 1992 May; 33(3):271-4. PubMed ID: 1591133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bestatin, a new immunomodulator, enhances migration and phagocytosis of human granulocytes in vitro.
    Jarstrand C; Blomgren H
    J Clin Lab Immunol; 1981 Jan; 5(1):67-9. PubMed ID: 7012355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mepacrine blockade of arachidonate-induced washed platelet aggregation: relationship to mepacrine inhibition of platelet cyclooxygenase.
    Raz A
    Thromb Haemost; 1983 Dec; 50(4):784-6. PubMed ID: 6420923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antiviral activity of mepacrine in relation to morphological changes produced by the drug.
    HURST EW; SNOW GA; ROBERTS DC
    Br J Exp Pathol; 1955 Jun; 36(3):215-25. PubMed ID: 13239976
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of oxidative hemolysis and lipid peroxidation by mepacrine.
    Nagai J; Tanaka M; Hibasami H; Ikeda T
    J Biochem; 1981 Apr; 89(4):1143-8. PubMed ID: 7251575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Increased locomotion, phagocytosis and bacteriocidal activities of granulocytes during lithium therapy].
    Ojima T; Kuratsuji T; Shimizu S; Lee JY; Takahashi E
    Rinsho Ketsueki; 1983 Jul; 24(7):850-4. PubMed ID: 6632224
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of various concentrations of cefotiam and ceftizoxime on the phagocytosis of gonococci by polymorphonuclear granulocytes.
    Korting HC; Seitz R; Kreller W
    Arzneimittelforschung; 1989 Apr; 39(4):428-31. PubMed ID: 2502124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The in vivo effect of colony stimulating factors (CSFs) on phagocytic functions of granulocytes.
    Szmitkowski M; Cimaszewska M; Kondracka E; Wysocka J
    Arch Immunol Ther Exp (Warsz); 1989; 37(5-6):593-600. PubMed ID: 2487368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of antimitotic drugs on the phagocytic activity of human granulocytes in vitro. I].
    Imperato S; Gremmo A; Villaggio B; Ciani A
    Boll Soc Ital Biol Sper; 1977 Apr; 53(8):665-70. PubMed ID: 907744
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of sodium azide on the chemiluminescence of granulocytes--evidence for the generation of multiple oxygen radicals.
    Sagone AL; Mendelson DS; Metz EN
    J Lab Clin Med; 1977 Jun; 89(6):1333-40. PubMed ID: 194005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological modulation of phagocytosis of granulocytes and monocytes in patients with familial Mediterranean fever].
    Avetisian SA
    Eksp Klin Farmakol; 2005; 68(5):40-3. PubMed ID: 16277210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unmodified phagocytosis after periodate treatment of human granulocytes separated by a two-step method using Ficoll-Hypaque and polyvinylic alcohol medium.
    Zenou SM; Raichvarg D; Agneray J
    Biomedicine; 1981 Oct; 35(5):166-9. PubMed ID: 6274440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of phospholipase inhibitor mepacrine on platelet aggregation, the platelet release reaction and fibrinogen binding to the platelet surface.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    Thromb Haemost; 1981 Jun; 45(3):257-62. PubMed ID: 7281105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug modification of the phagocytic capacity of granulocytes].
    Quadripur SA
    Ther Ggw; 1976 Jun; 115(6):1072-8. PubMed ID: 785681
    [No Abstract]   [Full Text] [Related]  

  • 17. Mepacrine antagonises tumour cell growth induced by natural polyamines.
    Rossi T; Coppi A; Bruni E; Ruberto A; Giudice S; Baggio G
    Anticancer Res; 2008; 28(5A):2765-8. PubMed ID: 19035307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro investigations of the effect of hydrocortisone on the functions of peripheral blood granulocytes.
    Sychlowy A
    Acta Med Pol; 1974; 15(1):39-43. PubMed ID: 4413810
    [No Abstract]   [Full Text] [Related]  

  • 19. A possible competition between 5'-monodeiodination of thyroxine and the respiratory burst in human granulocytes.
    Nagy JT; Szabó T; Komáromi I; Sztojka I; Fóris G; Leövey A
    Horm Metab Res; 1986 Jun; 18(6):415-7. PubMed ID: 3015757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased granulocyte phagocytosis after oral administration of bestatin, a new immunomodulator.
    Jarstrand C; Blomgren H
    J Clin Lab Immunol; 1982 Feb; 7(2):115-8. PubMed ID: 7069782
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.